logo
[breadcrumb_custom]

Tag: NASDAQ:STRO

ALXO Stock
Stock

Sutro Biopharma Inc Inc. (STRO) Price Performance: The Role of Share Buybacks and Stock Splits

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a gain of 2.33%.However, over the last six months, we can see a weaker performance of 18.97%. Over the last 30 days, the price of STRO has leaped by -6.00%. And in the last five days, it has fallen by -13.75%. In terms of market performance, Sutro Biopharma Inc had a fairly uneven. The highest value for the stock in the past year was $6.13 on 03/28/24, and

News

Sutro Biopharma Inc: Navigating Market Fluctuations with a 352.79M Market Cap

Sutro Biopharma Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $6.11 on 03/28/24, while the lowest price for the same duration was marked at $2.01 on 11/13/23. 52-week price history of STRO Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Sutro Biopharma Inc’s current trading price is -7.45% away from its 52-week high, while its distance from the 52-week low is 181.80%. The stock’s price range during this period has spanned from $2.01 to $6.11. In the Healthcare sector, the

Finance

STRO’s Market Whiplash: -2.56% YTD Decline, -13.01% Plunge in 30 Days

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant loss of -2.56% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 25.53%. Over the past 30 days, the price of STRO has leaped by -13.01%. And in the last five days, it has surged by 17.75%. Sutro Biopharma Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $6.11 on 05/16/23, while

News

STRO’s Market Quandary: Decoding the Ups and Downs of 2023

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -17.25% this year. Over the last six months, there has been a stronger performance of -5.84%. The price of STRO leaped by -18.01% during the last 30 days period. For the last 5-days stocks have slided -19.86%. Sutro Biopharma Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $6.11 on 05/16/23, and the lowest price during that time was

Stock

Sutro Biopharma Inc’s Banking’s 100-Day Moving Average at 3.79: Will the Stock Break Through?

The market performance of Sutro Biopharma Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $6.11 on 05/16/23, with the lowest value for the same timeframe being $2.01, recorded on 11/13/23. 52-week price history of STRO Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Sutro Biopharma Inc’s current trading price is -34.32% away from its 52-week high, while its distance from the 52-week low is 100.00%. The stock’s price range during this period has fluctuated between $2.01 and $6.11. Shares

ALXO Stock
News

Company’s Banking Stock: Dissecting a 54.42% Quarterly Revenue Decline Amid Growth

Sutro Biopharma Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $6.11 on 05/16/23, with the lowest value being $2.01 on 11/13/23. 52-week price history of STRO Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Sutro Biopharma Inc’s current trading price is -19.82% away from its 52-week high, while its distance from the 52-week low is 144.14%. The stock’s price range for this period has remained between $2.01 and $6.11. The Healthcare